These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 17925534

  • 1. Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence.
    Etzioni RD, Ankerst DP, Weiss NS, Inoue LY, Thompson IM.
    J Natl Cancer Inst; 2007 Oct 17; 99(20):1510-5. PubMed ID: 17925534
    [Abstract] [Full Text] [Related]

  • 2. Does PSA velocity predict prostate cancer in pre-screened populations?
    Schröder FH, Roobol MJ, van der Kwast TH, Kranse R, Bangma CH.
    Eur Urol; 2006 Mar 17; 49(3):460-5; discussion 465. PubMed ID: 16442212
    [Abstract] [Full Text] [Related]

  • 3. Prostate-specific antigen velocity (PSAV): a practical role for PSA?
    Thanigasalam R, Mancuso P, Tsao K, Rashid P.
    ANZ J Surg; 2009 Oct 17; 79(10):703-6. PubMed ID: 19878164
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The utility of prostate-specific antigen velocity thresholds in clinical practice: a population-based analysis.
    Connolly D, Black A, Murray LJ, Nambirajan T, Keane PF, Gavin A.
    BJU Int; 2008 Jun 17; 101(12):1507-12. PubMed ID: 18341627
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correction of prostate-specific antigen velocity for variation may improve prediction of cancer following prostate repeat biopsy.
    Kumar A, Godoy G, Taneja SS.
    Can J Urol; 2009 Jun 17; 16(3):4655-9. PubMed ID: 19497172
    [Abstract] [Full Text] [Related]

  • 8. Methods of calculating prostate-specific antigen velocity.
    Connolly D, Black A, Murray LJ, Napolitano G, Gavin A, Keane PF.
    Eur Urol; 2007 Oct 17; 52(4):1044-50. PubMed ID: 17197071
    [Abstract] [Full Text] [Related]

  • 9. PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate cancer aggressiveness.
    Loeb S, Sutherland DE, D'Amico AV, Roehl KA, Catalona WJ.
    Urology; 2008 Nov 17; 72(5):1116-20; discussion 1120. PubMed ID: 18571700
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics.
    Schröder FH, Carter HB, Wolters T, van den Bergh RC, Gosselaar C, Bangma CH, Roobol MJ.
    Eur Urol; 2008 Mar 17; 53(3):468-77. PubMed ID: 17997011
    [Abstract] [Full Text] [Related]

  • 13. Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy.
    Palma D, Tyldesley S, Pickles T, Prostate Cohort Outcomes Initiative.
    Cancer; 2008 May 01; 112(9):1941-8. PubMed ID: 18338814
    [Abstract] [Full Text] [Related]

  • 14. Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan.
    Takechi H, Ito K, Yamamoto T, Miyakubo M, Ohi M, Suzuki K.
    Urology; 2008 Nov 01; 72(5):1111-5. PubMed ID: 18342926
    [Abstract] [Full Text] [Related]

  • 15. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
    Bittner N, Merrick GS, Andreini H, Taubenslag W, Allen ZA, Butler WM, Anderson RL, Adamovich E, Wallner KE.
    Urology; 2009 Jul 01; 74(1):171-6. PubMed ID: 19232691
    [Abstract] [Full Text] [Related]

  • 16. The cautionary tale of PSA testing.
    Hoffman RM, Zeliadt SB.
    Arch Intern Med; 2010 Jul 26; 170(14):1262-3. PubMed ID: 20660847
    [No Abstract] [Full Text] [Related]

  • 17. PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer.
    Shimbo M, Tomioka S, Sasaki M, Shima T, Suzuki N, Murakami S, Nakatsu H, Shimazaki J.
    Jpn J Clin Oncol; 2009 Nov 26; 39(11):727-31. PubMed ID: 19674994
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?
    Mouraviev V, Broadwater G, Sun L, Mayes JM, Moul JW, Polascik TJ.
    Urology; 2008 Jun 26; 71(6):1020-3. PubMed ID: 18267331
    [Abstract] [Full Text] [Related]

  • 20. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy.
    Elmansy HM, Elzayat EA, Sampalis JS, Elhilali MM.
    Urology; 2009 Nov 26; 74(5):1105-10. PubMed ID: 19773035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.